Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
Completed · Early Phase 1 · Has a placebo group
Conditions studied: Type 1 Diabetes
In brief
The purpose of this study is to determine the way by which Alprazolam (Xanax) an anti-anxiety drug affects specialized molecules in your brain called GABA (A) receptors that alter your body's ability to defend itself from low blood sugar (hypoglycemia). We hypothesize that prior activation of GABA (A) receptors may result in blunting of counterregulatory responses during subsequent hypoglycemia and exercise.
Key facts
- Study ID
- NCT00574639
- Run by
- University of Maryland, Baltimore
- People needed
- 14
- Starts
- 2007-07-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2019-09-12
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Maryland, Baltimore — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.